Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone as an adjunct to surgery for chronic subdural haematoma
ACTRN12613000175774Phase 3Recruiting
- Sponsor
- Townsville University Hospital
- Start
- Nov 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Chronic subdural haematoma (CSDH) comparing Surgery + dexamethasone with Surgery + placebo (2 arms). Primary endpoint: Recurrence rate of chronic subdural haematoma. Started Nov 2013; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
Chronic subdural haematoma (CSDH)
Beyond the preview
Go deeper on ACTRN12613000175774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000175774.